PolyNovo Limited (ASX: PNV)

Market Cap	1.37B
Revenue (ttm)	103.23M
Net Income (ttm)	5.26M
Shares Out	690.76M
EPS (ttm)	0.01
PE Ratio	265.33
Forward PE	144.94
Dividend	n/a
Ex-Dividend Date	n/a

Volume	824,221
Open	2.040
Previous Close	2.030
Day's Range	1.960 - 2.050
52-Week Range	1.300 - 2.780
Beta	1.67
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2024

About PolyNovo

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal scaffold for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MT...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 254
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PNV